Active Ingredient History

  • Now
Neostigmine is a cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike physostigmine, does not cross the blood-brain barrier. By inhibiting acetylcholinesterase, more acetylcholine is available in the synapse, therefore, more of it can bind to the fewer receptors present in myasthenia gravis and can better trigger muscular contraction. Neostigmine is used for the symptomatic treatment of myasthenia gravis by improving muscle tone.   NCATS

More Chemistry
  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$6.3980 - $26.9900
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

3-trimethylammoniumphenyl n,n-dimethylcarbamate | eustigmin | eustigmine | (m-hydroxyphenyl)trimethylammonium dimethylcarbamate | m-trimethylammoniumphenyldimethylcarbamate | neostigimine | neostigmine | neostigmine bromide | neostigmine methylsulfate | neostigmine metilsulfate | prostigmin | prostigmine | robinul-neostig | vagostigmine


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue